ArticlePathogens (Basel, Switzerland)2021
WGS of Commensal
Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 35 citations in OpenAlex.
- Antimicrobial resistance in Neisseria gonorrhoeae and co-infections (Vienna, Austria; 2015-2024).Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Article
- CommensalAnnual review of microbiology · 2025Review
- Global genomic and antimicrobial resistance profiling of Neisseria gonorrhoeae: Insights from whole genome sequencing and minimum inhibitory concentration analysis.PLoS neglected tropical diseases · 2025Article
- Investigation of invasiveFrontiers in public health · 2025Article
- Antimicrobial susceptibilities of oral Neisseria from men on HIV pre-exposure prophylaxis in Hanoi, Vietnam.Journal of global antimicrobial resistance · 2025Article
- Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma.Journal of gastrointestinal oncology · 2024Article
- Gonococcal resistance to zoliflodacin could emerge via transformation from commensal Neisseria species. An in-vitro transformation study.Scientific reports · 2024Article
- Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach.The Lancet regional health. Europe · 2023Review
- Regulation of the macrolide resistance ABC-F translation factor MsrD.Nature communications · 2023Article
- Non-pathogenicFrontiers in cellular and infection microbiology · 2023Article
- The Discovery of Oropharyngeal Microbiota with Inhibitory Activity against PathogenicMicroorganisms · 2022Article
- Whole Genome Analyses Accurately IdentifyInternational journal of molecular sciences · 2022Article
- Review
- Ciprofloxacin Concentrations 1/1000th the MIC Can Select for Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2022Article
- Bioinformatics tools used for whole-genome sequencing analysis of Neisseria gonorrhoeae: a literature review.Briefings in functional genomics · 2022Review
- Antimicrobial susceptibility of commensal Neisseria in a general population and men who have sex with men in Belgium.Scientific reports · 2022Article
- Successful Intra- but Not Inter-species Recombination ofFrontiers in microbiology · 2022Article
- Evolutionary paths to macrolide resistance in a Neisseria commensal converge on ribosomal genes through short sequence duplications.PloS one · 2022Article
- Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Antibiotics (Basel, Switzerland) · 2021Article
- Conformational Changes in a Macrolide Antibiotic Binding Protein FromFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we characterized all oropharyngeal and anorectal isolates of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.